Bbot
BBOT (BridgeBio Oncology Therapeutics) is a clinical-stage biopharmaceutical company advancing a next generation pipeline of novel small molecule therapeutics targeting RAS and PI3K malignancies. Initially formed as a subsidiary of BridgeBio, BBOT completed a $200M private financing with external investors in 2024 with the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors.
7-day free trial · no credit card
Verified contacts
65
available on Kipplo
LinkedIn employees
94
51 to 200 range
Open roles
—
no listings
Distinct roles
23
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 65 verified contacts at Bbot
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
65 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Bbot
23 distinct titles indexed · top 10 shown.
- 6bridgebio oncology therapeutics (bbot)
- 2()
- 2executive assistant
- 1(, ())
- 1associate director, cmc business operations and project management
- 1cargo therapeutics
- 1clinical research associate
- 1director
- 1director of strategy and business development
- 1director, clinical scientist
- +13more titles
Sign up to unlock all 65 contacts at Bbot
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 65 verified contacts at Bbot
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.